Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1

[1]  Z. Su,et al.  Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells , 2010, Cancer Gene Therapy.

[2]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[3]  Gary D. Stormo,et al.  The AP-1 transcription factor Batf controls TH17 differentiation , 2009, Nature.

[4]  P. Fisher,et al.  Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN) , 2008, Proceedings of the National Academy of Sciences.

[5]  Carl W. Miller,et al.  Functional domains of CCN1 (Cyr61) regulate breast cancer progression. , 2008, International journal of oncology.

[6]  Z. Su,et al.  Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling , 2008, Oncogene.

[7]  N. Colburn,et al.  AP-1 a target for cancer prevention. , 2007, Current cancer drug targets.

[8]  E. Taparowsky,et al.  Sensitivity of NK1.1-Negative NKT Cells to Transgenic BATF Defines a Role for Activator Protein-1 in the Expansion and Maturation of Immature NKT Cells in the Thymus1 , 2007, The Journal of Immunology.

[9]  R. Graham,et al.  Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. , 2006, Cancer research.

[10]  Dong Xie,et al.  Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells , 2005, Clinical Cancer Research.

[11]  P. Fisher,et al.  Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Takeda,et al.  Analysis of gene expression during staurosporine-induced neuronal differentiation of human prostate cancer cells. , 2005, Oncology reports.

[13]  J. O'kelly,et al.  THE ROLE OF CCN1 IN TUMORIGENESIS AND CANCER PROGRESSION , 2005 .

[14]  J. Menéndez,et al.  αVβ3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer , 2005, Oncogene.

[15]  D. Griggs,et al.  A novel CYR61-triggered ‘CYR61-αvβ3 integrin loop’ regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway , 2005, Oncogene.

[16]  G. Watkins,et al.  Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.

[17]  Y. Liu,et al.  Targeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61) , 2004, Journal of Biological Chemistry.

[18]  P. Fisher,et al.  Bcl-2 and Bcl-xL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24 , 2003, Oncogene.

[19]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[20]  J. Thiery,et al.  Integrins in Mammary Gland Development and Differentiation of Mammary Epithelium , 2003, Journal of Mammary Gland Biology and Neoplasia.

[21]  J. Rosenbloom,et al.  Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways. , 2003, European journal of biochemistry.

[22]  P. Fisher,et al.  Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner , 2003, Oncogene.

[23]  R. Lupu,et al.  Cyr61 promotes breast tumorigenesis and cancer progression , 2002, Oncogene.

[24]  M. Bissell,et al.  The dominance of the microenvironment in breast and ovarian cancer. , 2002, Seminars in cancer biology.

[25]  R. Lupu,et al.  Expression and regulation of Cyr61 in human breast cancer cell lines , 2002, Oncogene.

[26]  P. Fisher,et al.  The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells , 2002, Oncogene.

[27]  L. Lau,et al.  The Angiogenic Factor Cyr61 Activates a Genetic Program for Wound Healing in Human Skin Fibroblasts* , 2001, The Journal of Biological Chemistry.

[28]  S. Hilsenbeck,et al.  AP-1 blockade inhibits the growth of normal and malignant breast cells , 2001, Oncogene.

[29]  G. Lyons,et al.  Characterization of murine BATF: a negative regulator of activator protein‐1 activity in the thymus , 2001, European journal of immunology.

[30]  T. Kerppola,et al.  Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity , 2001, Oncogene.

[31]  Carl W. Miller,et al.  Breast Cancer , 2001, The Journal of Biological Chemistry.

[32]  Z. Su,et al.  PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells. , 2001, Nucleic acids research.

[33]  J W Smith,et al.  Integrin activation controls metastasis in human breast cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Gary R. Grotendorst,et al.  CCN proteins are distinct from, and should not be considered members of, the insulin-like growth factor-binding protein superfamily. , 2000, The Journal of clinical endocrinology and metabolism.

[35]  N. Mitin,et al.  B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos , 2000, Oncogene.

[36]  D. Brigstock.  The Connective Tissue Growth Factor/cysteine- Rich 61/nephroblastoma Overexpressed (ccn) Family* , 2022 .

[37]  Z. Su,et al.  The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Castellazzi,et al.  Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization , 1996, Molecular and cellular biology.

[39]  P. Bork.  The modular architecture of a new family of growth regulators related to connective tissue growth factor , 1993, FEBS letters.

[40]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[41]  R. Bravo,et al.  c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. , 1991, Oncogene.

[42]  P. Vogt,et al.  Avian sarcoma virus 17 carries the jun oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Menéndez,et al.  AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. , 2005, Oncogene.

[44]  Xin Chen,et al.  TRANSFAC: an integrated system for gene expression regulation , 2000, Nucleic Acids Res..